Europe - France
2

Capital markets: equity capital markets

logo

Jones Day

More informationMore information

Jones Day is a reference for French and US ECM work in the biotech and tech sectors, notably on the Euronext Growth segment, through the Parisian team's combined US and French ECM expertise. The firm assists many startups and biotech companies with their ECM needs including share capital increase, IPOs and private placement transactions. The team is co-headed by US expert Linda Hesse , Florent Bouyer and Renaud Bonnet. Charles Gavoty  and counsel Seth Engel  also contributes.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘Pleasant and efficient team. Good work capacity. Pragmatic approach.'

  • ‘Florent Bouyer is very friendly, conscientious and knows the market well.'

  • ‘Florent Bouyer: great expertise, recognised for techs and biotechs in particular.'

  • ‘Exceptional quality, customer relations and responsiveness. Excellent collaboration and synergy between team members, particularly appreciable on operations with a US component. A very friendly team, on which one can always count even in emergency situations, and with whom one can work in complete confidence.'

  • ‘Florent Bouyer is very accessible, pragmatic and technical.'

  • ‘Linda Hesse has a great command of her subjects and knows how to surround herself to provide pragmatic answers in the interest of clients. Seth Engel knows how to advance the most specific files while remaining calm and pragmatic.'

  • ‘This team provides high-quality legal advice, taking into account the client's constraints and needs without compromising on legal rigor and with unfailing availability and patience, not forgetting exceptional technical skills.'

  • ‘Linda Hesse: availability, teaching skills and extensive experience in the subjects covered, which is a major asset for this type of project. Seth Engel: availability, patience, precision and undeniable technical skills in the subjects covered.'

Key clients

  • Sanofi
  • BNP Paribas
  • EUROAPI
  • Voltalia
  • Natixis
  • Carmat
  • Cellectis
  • Waga Energy
  • Genfit
  • Criteo
  • Arverne
  • Nanobiotix
  • Bryan Garnier & Co Limited
  • Orange
  • Valneva
  • Innate Pharma
  • Bank of America

Work highlights

  • Advised Arverne Group SAS on its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • Represented Cellectis as both French and U.S. counsel, in the context of an initial share capital increase of USD 80 million and the issue of 16 million ordinary shares, followed by a second share capital increase of USD 140 million and the issue of preferred shares to AstraZeneca.
  • Represented Waga Energy, as French Counsel, in a EUR 52 million equity fundraising via an accelerated bookbuilding process.

Lawyers

Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.

Practice head

The lawyer(s) leading their teams.

Linda Hesse, Renaud Bonnet, Florent Bouyer

Other key lawyers

Charles Gavoty, Seth Engel